Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",22080,202,1.21 [1.04-1.40],0.0121947143991812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACE2,Angiotensin-converting enzyme 2,22162,199,1.30 [1.05-1.62],0.0151860334662972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACP1,Low molecular weight phosphotyrosine protein phosphatase,19069,160,0.60 [0.41-0.87],0.0074077330330009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACTA2,"Actin, aortic smooth muscle",22162,199,1.43 [1.14-1.80],0.0022415316767285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACTN2,Alpha-actinin-2,18980,160,1.39 [1.10-1.75],0.0052221044331607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACVRL1,Serine/threonine-protein kinase receptor R3,22352,209,1.77 [1.13-2.78],0.0126005719714687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADA2,Adenosine deaminase 2,22474,211,1.49 [1.14-1.95],0.003757807724908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,22673,210,0.73 [0.56-0.96],0.0218621097309336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRG1,Adhesion G-protein coupled receptor G1,22474,209,1.21 [1.06-1.37],0.0049790088529344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADM,Pro-adrenomedullin,22761,210,1.69 [1.05-2.71],0.0309672615291429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGR2,Anterior gradient protein 2 homolog,21872,198,1.23 [1.09-1.39],0.0008670443330032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGRN,Agrin,22676,208,1.65 [1.21-2.26],0.0016942734008461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGXT,Serine--pyruvate aminotransferase,22584,212,1.22 [1.05-1.42],0.0095864297924455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AIFM1,"Apoptosis-inducing factor 1, mitochondrial",22441,209,1.13 [1.01-1.27],0.0352236431020648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALDH2,"Aldehyde dehydrogenase, mitochondrial",19559,167,1.25 [1.01-1.53],0.0387196935949653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMBP,Protein AMBP,22725,210,2.04 [1.14-3.64],0.0160012341880475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMFR,E3 ubiquitin-protein ligase AMFR,22060,200,1.34 [1.14-1.57],0.0004170985910877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMN,Protein amnionless,22144,200,1.39 [1.08-1.78],0.0096531718817005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMPD3,AMP deaminase 3,19617,166,0.79 [0.65-0.98],0.0278173951244235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPT2,Angiopoietin-2,22761,210,1.39 [1.01-1.90],0.044557215265058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPTL4,Angiopoietin-related protein 4,22636,206,1.51 [1.14-1.98],0.0036620801941266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANPEP,Aminopeptidase N,22673,212,1.74 [1.16-2.61],0.007046983809617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOF,Apolipoprotein F,19664,165,0.61 [0.43-0.86],0.0048198928996305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOH,Beta-2-glycoprotein 1,22610,209,1.39 [1.02-1.90],0.0372751035676118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APP,Amyloid-beta precursor protein,22583,209,1.23 [1.02-1.47],0.0264726999028643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AREG,Amphiregulin,22474,209,1.88 [1.48-2.38],2.1243354098205803e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARG1,Arginase-1,22415,206,0.78 [0.61-0.98],0.0332838847039437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASGR1,Asialoglycoprotein receptor 1,22387,210,1.85 [1.27-2.69],0.0012128313212257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATOX1,Copper transport protein ATOX1,22673,210,1.23 [1.03-1.47],0.0244592148884441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP1B4,Protein ATP1B4,18946,158,1.41 [1.05-1.90],0.0232049449420992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AXL,Tyrosine-protein kinase receptor UFO,22706,212,1.83 [1.20-2.79],0.0049113647039862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),B4GALT1,"Beta-1,4-galactosyltransferase 1",22676,208,1.91 [1.24-2.92],0.0030521665689566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAG3,BAG family molecular chaperone regulator 3,22352,209,1.40 [1.02-1.91],0.0369988391255713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,22080,202,1.24 [1.03-1.48],0.0239237429150664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAMBI,BMP and activin membrane-bound inhibitor homolog,22080,202,1.94 [1.34-2.81],0.0004727863897232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BEX3,Protein BEX3,18946,158,1.30 [1.02-1.65],0.0328891005784051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BGLAP,Osteocalcin,19664,164,0.83 [0.70-0.97],0.0221599475834283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BLNK,B-cell linker protein,19069,160,0.63 [0.40-0.99],0.0443086136772305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRK1,Protein BRICK1,22060,200,1.35 [1.03-1.77],0.0288227930043192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BST2,Bone marrow stromal antigen 2,22765,209,1.47 [1.21-1.78],8.850747358154378e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTN2A1,Butyrophilin subfamily 2 member A1,22676,208,2.14 [1.42-3.21],0.0002533727739964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTN3A2,Butyrophilin subfamily 3 member A2,22522,211,1.37 [1.03-1.83],0.0326694613001827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C19orf12,Protein C19orf12,22060,200,1.21 [1.02-1.43],0.0291365161636323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,19204,159,0.71 [0.53-0.95],0.0202279804904283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C2,Complement C2,22659,212,2.03 [1.11-3.70],0.0214141101079187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C7,Complement component C7,19204,162,1.91 [1.19-3.08],0.0078535207836523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA12,Carbonic anhydrase 12,22474,209,1.50 [1.04-2.15],0.0302227483765652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA5A,"Carbonic anhydrase 5A, mitochondrial",22162,199,1.19 [1.05-1.36],0.0077786499428839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA6,Carbonic anhydrase 6,22543,208,0.77 [0.64-0.94],0.0098913824906933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,22080,202,1.48 [1.16-1.90],0.0018817273307688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CANT1,Soluble calcium-activated nucleotidase 1,22505,212,1.82 [1.01-3.28],0.0458683286289182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAPN3,Calpain-3,19559,167,1.35 [1.00-1.82],0.0484779791787396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CBLN4,Cerebellin-4,22761,210,0.56 [0.39-0.82],0.0024980538262543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL14,C-C motif chemokine 14,22556,211,1.39 [1.06-1.83],0.018872602136288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL18,C-C motif chemokine 18,22293,209,1.19 [1.01-1.39],0.0346300016484552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL21,C-C motif chemokine 21,22676,208,1.29 [1.01-1.64],0.0414948372823005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL3,C-C motif chemokine 3,22522,211,1.19 [1.02-1.40],0.0307775701152341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCN3,CCN family member 3,22826,211,1.55 [1.12-2.16],0.0088238317893692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCN4,CCN family member 4,22761,210,1.37 [1.03-1.84],0.0318737906809493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD163,Scavenger receptor cysteine-rich type 1 protein M130,22706,212,1.40 [1.06-1.84],0.0160938036166809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD164,Sialomucin core protein 24,22610,209,1.39 [1.02-1.88],0.0343783999536452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD244,Natural killer cell receptor 2B4,22801,212,1.85 [1.20-2.83],0.0050468775668444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD27,CD27 antigen,22673,210,1.51 [1.16-1.98],0.0022683492677756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD274,Programmed cell death 1 ligand 1,22387,210,1.67 [1.22-2.27],0.0011660654062514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD276,CD276 antigen,22569,205,1.47 [1.03-2.08],0.0327736521641426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD28,T-cell-specific surface glycoprotein CD28,22080,202,1.40 [1.05-1.87],0.0230847740519814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD300C,CMRF35-like molecule 6,22765,209,1.96 [1.41-2.71],5.206898321054816e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD300E,CMRF35-like molecule 2,22686,210,1.52 [1.15-2.00],0.0029670585925322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD302,CD302 antigen,22474,209,1.71 [1.19-2.46],0.0035714304595029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD40,Tumor necrosis factor receptor superfamily member 5,22570,206,1.45 [1.15-1.83],0.0016796587097541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD46,Membrane cofactor protein,22482,211,1.71 [1.17-2.51],0.0060945934636307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD48,CD48 antigen,22636,206,1.84 [1.25-2.71],0.0021230962242861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD59,CD59 glycoprotein,21801,197,2.21 [1.43-3.42],0.0003710419514553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD74,HLA class II histocompatibility antigen gamma chain,22765,209,1.57 [1.12-2.19],0.0085878784997753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD80,T-lymphocyte activation antigen CD80,19653,166,1.79 [1.20-2.66],0.0040703436222393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD83,CD83 antigen,22522,211,1.46 [1.04-2.04],0.0300416262825108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD99,CD99 antigen,22610,209,2.33 [1.31-4.16],0.0040135009521274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD99L2,CD99 antigen-like protein 2,22610,209,2.27 [1.39-3.69],0.0009988414680916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDCP1,CUB domain-containing protein 1,22387,210,1.37 [1.11-1.70],0.0034415086831657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH1,Cadherin-1,21866,208,1.48 [1.14-1.92],0.0034686057323068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH3,Cadherin-3,22765,209,1.39 [1.01-1.92],0.0428458476717005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH4,Cadherin-4,19004,158,1.33 [1.04-1.72],0.0255901341843041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,22522,211,1.20 [1.05-1.37],0.0078731280395873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP20,Centrosomal protein 20,22080,202,1.20 [1.02-1.41],0.0266283735109355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP85,Centrosomal protein of 85 kDa,22080,202,1.24 [1.03-1.50],0.0204509517063128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFC1,Cryptic protein,22080,202,1.34 [1.05-1.71],0.0196273633227664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFHR4,Complement factor H-related protein 4,19647,164,1.33 [1.07-1.65],0.0106335136605622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFP,Properdin,19683,165,0.46 [0.22-0.97],0.0398970364227656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CGREF1,Cell growth regulator with EF hand domain protein 1,22584,212,1.40 [1.06-1.84],0.0169246204538189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",19617,166,1.59 [1.16-2.17],0.0038252410067885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHGB,Secretogranin-1,22699,209,1.51 [1.14-1.99],0.0040426089605156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHI3L1,Chitinase-3-like protein 1,22135,207,1.20 [1.04-1.38],0.0106741662720145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHRDL1,Chordin-like protein 1,22636,206,1.62 [1.11-2.38],0.0132834073769131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CKAP4,Cytoskeleton-associated protein 4,22703,212,1.49 [1.01-2.21],0.0464315544812738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC11A,C-type lectin domain family 11 member A,22575,209,1.29 [1.00-1.66],0.0494845937147848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC14A,C-type lectin domain family 14 member A,22610,209,1.52 [1.06-2.18],0.0235667087762331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC5A,C-type lectin domain family 5 member A,22520,212,1.49 [1.01-2.21],0.0454320081434042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC6A,C-type lectin domain family 6 member A,22080,202,1.30 [1.01-1.68],0.0450297551209951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC7A,C-type lectin domain family 7 member A,22801,212,1.32 [1.04-1.69],0.0233622626813337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNDP1,Beta-Ala-His dipeptidase,22706,212,0.78 [0.61-1.00],0.0476923016089326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTN5,Contactin-5,22627,209,0.50 [0.36-0.71],6.692589561734579e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL18A1,Collagen alpha-1(XVIII) chain,22706,212,2.33 [1.41-3.85],0.0009163314842354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL28A1,Collagen alpha-1(XXVIII) chain,19122,159,0.74 [0.60-0.92],0.0055469770457837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL4A1,Collagen alpha-1(IV) chain,22584,212,1.52 [1.13-2.04],0.0059403903854259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL6A3,Collagen alpha-3(VI) chain,22865,212,1.64 [1.20-2.23],0.0017794786522777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COLEC12,Collectin-12,22569,205,2.11 [1.37-3.23],0.0006268725523551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPM,Carboxypeptidase M,22646,209,1.51 [1.07-2.14],0.0200394896463217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPXM1,Probable carboxypeptidase X1,22673,210,1.23 [1.04-1.46],0.0163965711922266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CREB3,Cyclic AMP-responsive element-binding protein 3,18946,158,1.35 [1.09-1.68],0.0063870137550761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CREBZF,CREB/ATF bZIP transcription factor,18946,158,1.76 [1.07-2.90],0.0264014308475343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRHBP,Corticotropin-releasing factor-binding protein,22569,205,1.62 [1.03-2.53],0.0356769960849438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRIM1,Cysteine-rich motor neuron 1 protein,22676,208,2.62 [1.48-4.64],0.0009973465436482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRIP2,Cysteine-rich protein 2,22387,210,1.38 [1.04-1.84],0.0235304929091214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRNN,Cornulin,21959,204,1.20 [1.00-1.43],0.0468855785795781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRTAC1,Cartilage acidic protein 1,22865,212,0.67 [0.45-0.99],0.0448260097998637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRTAM,Cytotoxic and regulatory T-cell molecule,22387,210,1.35 [1.06-1.70],0.0136713294440339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRYBB2,Beta-crystallin B2,19617,166,1.41 [1.28-1.56],2.0022810477720022e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF1,Macrophage colony-stimulating factor 1,22676,208,1.95 [1.27-3.00],0.0021813931140916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CST3,Cystatin-C,22669,212,1.88 [1.28-2.76],0.001323639963111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTHRC1,Collagen triple helix repeat-containing protein 1,19664,164,1.84 [1.14-2.97],0.0128895162036766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSS,Cathepsin S,17659,168,1.89 [1.03-3.48],0.0396975580372062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSV,Cathepsin L2,22686,210,0.71 [0.53-0.97],0.0300462580570803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CX3CL1,Fractalkine,22387,210,1.48 [1.05-2.10],0.0256771463530763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXADR,Coxsackievirus and adenovirus receptor,22522,211,1.52 [1.23-1.87],9.504240553302478e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL10,C-X-C motif chemokine 10,22676,208,1.25 [1.06-1.48],0.0085931308809082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL14,C-X-C motif chemokine 14,22144,200,1.23 [1.04-1.46],0.0181973593624264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL16,C-X-C motif chemokine 16,22836,212,2.09 [1.27-3.43],0.0037305464912099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL9,C-X-C motif chemokine 9,22676,208,1.20 [1.01-1.42],0.0366397918132095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",18980,160,0.80 [0.64-1.00],0.0490827010299307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DAG1,Dystroglycan,22676,208,1.30 [1.00-1.69],0.0489267818250037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DBI,Acyl-CoA-binding protein,22509,207,1.20 [1.02-1.40],0.025601128536036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",22673,210,1.78 [1.27-2.50],0.0009239284675142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",22474,209,1.32 [1.01-1.71],0.0389246641083407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DEFB103A_DEFB103B,Beta-defensin 103,18910,158,1.31 [1.01-1.71],0.0421131679918109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DLL1,Delta-like protein 1,22673,210,1.64 [1.12-2.41],0.0110353834911188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPY30,Protein dpy-30 homolog,22679,209,1.22 [1.01-1.47],0.0418687485418255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DSC2,Desmocollin-2,22384,207,1.78 [1.29-2.45],0.0004160033692827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DTNB,Dystrobrevin beta,19517,167,1.47 [1.06-2.04],0.0204486409710106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ECE1,Endothelin-converting enzyme 1,22060,200,1.56 [1.17-2.08],0.002657610091857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDA2R,Tumor necrosis factor receptor superfamily member 27,22761,210,1.81 [1.36-2.41],4.775764432156295e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,22677,212,1.71 [1.18-2.48],0.0048943506502597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFNA1,Ephrin-A1,22578,209,2.34 [1.62-3.39],6.097845429560946e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFNA4,Ephrin-A4,22352,209,2.19 [1.61-2.96],4.75336738080647e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EGFR,Epidermal growth factor receptor,22865,212,0.33 [0.16-0.67],0.0024546696204657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ELOB,Elongin-B,18980,160,1.53 [1.20-1.95],0.000518704075991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENAH,Protein enabled homolog,22144,200,1.33 [1.04-1.70],0.0249255279104908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,22080,202,1.34 [1.02-1.76],0.0369923619847546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHA1,Ephrin type-A receptor 1,22646,208,1.48 [1.01-2.16],0.043307655687543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHA2,Ephrin type-A receptor 2,21758,196,1.71 [1.21-2.39],0.0020579443285415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHB4,Ephrin type-B receptor 4,22865,212,2.17 [1.42-3.33],0.0003863617881775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,22716,209,1.55 [1.06-2.27],0.0222208328221897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ESAM,Endothelial cell-selective adhesion molecule,22865,212,1.68 [1.17-2.42],0.0046790705636211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F11,Coagulation factor XI,19404,162,1.52 [1.02-2.27],0.0398623272582979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F11R,Junctional adhesion molecule A,22610,209,1.29 [1.04-1.59],0.020154593236913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F2R,Proteinase-activated receptor 1,22636,206,1.33 [1.07-1.66],0.0092389512034592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP1,"Fatty acid-binding protein, liver",22569,205,1.34 [1.19-1.51],2.178387352179046e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP2,"Fatty acid-binding protein, intestinal",22584,212,1.27 [1.10-1.47],0.0009844653982823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP3,"Fatty acid-binding protein, heart",19653,166,1.43 [1.10-1.86],0.0073815068897776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP4,"Fatty acid-binding protein, adipocyte",22865,212,1.28 [1.01-1.61],0.0370750713505917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP5,Fatty acid-binding protein 5,22680,209,1.24 [1.04-1.47],0.0150650534490251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM3B,Protein FAM3B,22474,209,1.73 [1.20-2.47],0.0030424820601655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM3C,Protein FAM3C,22541,212,2.02 [1.38-2.95],0.0002877957662704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAP,Prolyl endopeptidase FAP,22865,212,0.59 [0.38-0.92],0.019752741643435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAS,Tumor necrosis factor receptor superfamily member 6,22799,212,1.51 [1.18-1.94],0.0011973652106688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGA,Fibrinogen alpha chain,19226,162,0.53 [0.32-0.87],0.0126347328363812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF2,Fibroblast growth factor 2,22522,211,1.21 [1.02-1.43],0.0292640819952509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF23,Fibroblast growth factor 23,22728,210,1.25 [1.02-1.53],0.0283265200549275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF5,Fibroblast growth factor 5,22144,200,1.51 [1.06-2.16],0.0230045298224468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGFBP1,Fibroblast growth factor-binding protein 1,22673,210,0.58 [0.40-0.84],0.0039159268282445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGL1,Fibrinogen-like protein 1,19664,165,1.39 [1.11-1.74],0.0041512436522032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FLI1,Friend leukemia integration 1 transcription factor,22080,202,1.12 [1.00-1.25],0.0424035796844678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FLRT2,Leucine-rich repeat transmembrane protein FLRT2,22387,210,1.64 [1.08-2.50],0.0207721925456225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOLR2,Folate receptor beta,22765,209,1.88 [1.26-2.82],0.0022042795794068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FSTL3,Follistatin-related protein 3,22529,205,1.89 [1.34-2.67],0.0003118284190168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,22474,209,1.57 [1.02-2.43],0.0420840917616122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,22761,210,0.58 [0.37-0.91],0.017325598182625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAS6,Growth arrest-specific protein 6,22734,212,2.07 [1.28-3.35],0.0031200547093429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GBP4,Guanylate-binding protein 4,22060,200,1.29 [1.02-1.63],0.0309917922996466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",22474,209,1.48 [1.05-2.09],0.0255206102646194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GDF15,Growth/differentiation factor 15,22865,212,1.95 [1.58-2.41],6.702755265285281e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFAP,Glial fibrillary acidic protein,22042,202,1.44 [1.14-1.83],0.002563008789932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFER,FAD-linked sulfhydryl oxidase ALR,22080,202,1.23 [1.01-1.49],0.0381647372776072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFRA1,GDNF family receptor alpha-1,22724,210,2.24 [1.52-3.31],5.0818141494602805e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GGT1,Glutathione hydrolase 1 proenzyme,22578,209,1.41 [1.13-1.76],0.0021745986312981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GGT5,Glutathione hydrolase 5 proenzyme,22387,210,1.72 [1.04-2.86],0.0358822005776112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GHR,Growth hormone receptor,19241,159,0.44 [0.26-0.76],0.0029230841933675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GKN1,Gastrokine-1,21640,195,1.59 [1.03-2.44],0.0369389359806066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPNMB,Transmembrane glycoprotein NMB,21965,209,2.09 [1.37-3.19],0.0006253278714878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPR15L,Protein GPR15L,19559,166,1.37 [1.09-1.73],0.0074857072812105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPR37,Prosaposin receptor GPR37,22162,199,1.45 [1.20-1.75],9.165505541296724e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPRC5C,G-protein coupled receptor family C group 5 member C,19559,167,1.37 [1.10-1.71],0.0045975795175428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRPEL1,"GrpE protein homolog 1, mitochondrial",22474,209,1.40 [1.16-1.68],0.000426775462015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GUCA2A,Guanylin,22495,207,1.84 [1.33-2.54],0.0002367639666232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HAO1,Hydroxyacid oxidase 1,22761,210,1.10 [1.00-1.21],0.047770691434941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HAVCR1,Hepatitis A virus cellular receptor 1,22725,210,1.40 [1.17-1.67],0.0001858801765814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HAVCR2,Hepatitis A virus cellular receptor 2,22610,209,1.97 [1.45-2.70],1.8878457964292653e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HBQ1,Hemoglobin subunit theta-1,22761,210,0.79 [0.64-0.97],0.0220770326722722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HEPACAM2,HEPACAM family member 2,19617,166,0.65 [0.46-0.93],0.0177131989429376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HLA-E,"HLA class I histocompatibility antigen, alpha chain E",22522,211,1.59 [1.09-2.33],0.0160709140731607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMOX2,Heme oxygenase 2,22060,200,1.49 [1.20-1.84],0.0002511463814697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HNMT,Histamine N-methyltransferase,22284,209,1.36 [1.05-1.75],0.0182531553783114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSPB6,Heat shock protein beta-6,22761,210,1.56 [1.16-2.09],0.003094992097396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,22439,211,1.68 [1.10-2.55],0.015497226485744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HTRA2,"Serine protease HTRA2, mitochondrial",22673,210,1.24 [1.02-1.51],0.032411822130697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HYOU1,Hypoxia up-regulated protein 1,22865,212,2.20 [1.32-3.69],0.0026651396857735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IDI2,Isopentenyl-diphosphate delta-isomerase 2,22060,200,1.33 [1.06-1.67],0.014624294115598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFI30,Gamma-interferon-inducible lysosomal thiol reductase,19068,163,1.48 [1.03-2.13],0.0326541144041683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNGR1,Interferon gamma receptor 1,22676,208,1.99 [1.16-3.41],0.0121059993060836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNL1,Interferon lambda-1,22060,200,1.36 [1.05-1.75],0.0185862808055566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGF2R,Cation-independent mannose-6-phosphate receptor,22610,209,1.95 [1.16-3.31],0.0125159086914274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP2,Insulin-like growth factor-binding protein 2,22837,212,1.28 [1.05-1.56],0.0160172741587694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP3,Insulin-like growth factor-binding protein 3,22706,212,0.62 [0.44-0.89],0.008522333958046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP4,Insulin-like growth factor-binding protein 4,22317,205,1.57 [1.24-2.00],0.0002090580014751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP6,Insulin-like growth factor-binding protein 6,22506,209,1.50 [1.05-2.17],0.028031962208108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP7,Insulin-like growth factor-binding protein 7,22865,212,1.44 [1.01-2.04],0.0427851112837593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGSF8,Immunoglobulin superfamily member 8,22584,212,1.66 [1.15-2.40],0.0066945293503593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL12RB1,Interleukin-12 receptor subunit beta-1,22144,200,1.46 [1.07-1.99],0.0181729766454596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL15RA,Interleukin-15 receptor subunit alpha,22144,200,1.78 [1.26-2.53],0.0012215985217433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL17C,Interleukin-17C,22144,200,1.34 [1.17-1.54],2.4112048906022565e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL18BP,Interleukin-18-binding protein,22706,212,1.72 [1.20-2.45],0.0029876376248146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL18R1,Interleukin-18 receptor 1,22801,212,1.62 [1.13-2.33],0.0081232227727742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1RL1,Interleukin-1 receptor-like 1,22799,212,1.54 [1.18-2.02],0.0015987438641792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL22,Interleukin-22,19559,167,1.23 [1.01-1.49],0.0419620176088765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL2RA,Interleukin-2 receptor subunit alpha,22403,203,1.47 [1.12-1.94],0.005957073586514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL4R,Interleukin-4 receptor subunit alpha,22522,211,1.38 [1.01-1.89],0.0461806972704173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IMMT,MICOS complex subunit MIC60,19559,167,1.47 [1.12-1.92],0.005644994991088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INSL3,Insulin-like 3,19617,166,0.82 [0.69-0.99],0.0341586236419481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INSL5,Insulin-like peptide INSL5,19559,166,1.26 [1.09-1.45],0.0014829344166622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGA11,Integrin alpha-11,22522,211,0.63 [0.44-0.90],0.012098740472832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGA5,Integrin alpha-5,22610,209,1.65 [1.02-2.67],0.0423239111263784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGAV,Integrin alpha-V,22761,210,0.39 [0.18-0.81],0.0114642797482951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,22706,212,1.57 [1.13-2.17],0.0073361277065826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),JAM2,Junctional adhesion molecule B,22765,209,1.58 [1.03-2.42],0.0366775594114833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),JUN,Transcription factor AP-1,22144,200,1.29 [1.06-1.57],0.0126041229717084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK11,Kallikrein-11,22465,210,1.72 [1.33-2.24],4.273981637207728e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK4,Kallikrein-4,22761,210,1.34 [1.13-1.60],0.0009256746311522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK6,Kallikrein-6,22630,210,1.53 [1.03-2.25],0.0338224994360642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLRB1,Killer cell lectin-like receptor subfamily B member 1,22801,212,1.63 [1.21-2.19],0.0012160536549732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT18,"Keratin, type I cytoskeletal 18",22474,209,1.17 [1.01-1.35],0.0345722497792434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT19,"Keratin, type I cytoskeletal 19",22475,210,1.23 [1.04-1.46],0.0152531410822611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT5,"Keratin, type II cytoskeletal 5",22060,200,1.32 [1.05-1.67],0.0164483823522251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,22569,205,1.75 [1.36-2.26],1.710317210922507e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMA4,Laminin subunit alpha-4,22676,208,1.61 [1.13-2.31],0.0087299492190991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAP3,Cytosol aminopeptidase,22144,200,1.33 [1.07-1.65],0.0116565380970623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAYN,Layilin,22352,210,1.81 [1.34-2.45],0.0001236616325793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LBP,Lipopolysaccharide-binding protein,22706,212,1.46 [1.19-1.79],0.000325077684959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LCAT,Phosphatidylcholine-sterol acyltransferase,19664,165,0.57 [0.35-0.94],0.0268292102207475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LDLR,Low-density lipoprotein receptor,22646,207,0.77 [0.60-0.98],0.0343481189818929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LEO1,RNA polymerase-associated protein LEO1,19611,164,1.36 [1.01-1.85],0.0459703089880262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LETM1,Mitochondrial proton/calcium exchanger protein,19611,164,1.39 [1.08-1.79],0.0106449074166015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS1,Galectin-1,22584,212,1.44 [1.03-2.01],0.0306314184346306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS4,Galectin-4,22569,205,1.44 [1.17-1.77],0.000556725417911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS9,Galectin-9,22570,206,1.98 [1.38-2.86],0.0002301142312121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,22541,212,1.47 [1.01-2.15],0.0438582426950109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,22144,200,1.52 [1.17-1.99],0.0020366952238429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRP11,Low-density lipoprotein receptor-related protein 11,22584,212,1.55 [1.12-2.13],0.0074360518825421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTA4H,Leukotriene A-4 hydrolase,22761,210,1.31 [1.08-1.59],0.0070963465387557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTBP2,Latent-transforming growth factor beta-binding protein 2,22865,212,1.62 [1.13-2.35],0.0096292247795443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTBP3,Latent-transforming growth factor beta-binding protein 3,22080,202,1.32 [1.08-1.61],0.0063213468087538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTBR,Tumor necrosis factor receptor superfamily member 3,22473,205,1.78 [1.21-2.63],0.0036923274418705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LY6D,Lymphocyte antigen 6D,22470,207,1.57 [1.19-2.07],0.0012891562734492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LY96,Lymphocyte antigen 96,22387,210,1.42 [1.04-1.95],0.0279871975318574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,22308,210,1.34 [1.12-1.61],0.0013519263410722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MATN2,Matrilin-2,22603,205,1.60 [1.05-2.43],0.027265467235485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MB,Myoglobin,22865,212,1.36 [1.10-1.67],0.0042659359456577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MCFD2,Multiple coagulation factor deficiency protein 2,22469,212,1.46 [1.11-1.91],0.0069559129387626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MDK,Midkine,22610,209,1.38 [1.15-1.67],0.0006981614222703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MEP1B,Meprin A subunit beta,22584,212,0.91 [0.82-1.00],0.049694962640527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MERTK,Tyrosine-protein kinase Mer,22801,212,1.85 [1.16-2.94],0.0091602672913133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MET,Hepatocyte growth factor receptor,22645,207,1.87 [1.01-3.46],0.0449985180576984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MILR1,Allergin-1,22144,200,1.30 [1.03-1.65],0.0291276296115134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MME,Neprilysin,22474,209,1.21 [1.05-1.40],0.0099245195765818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP1,Interstitial collagenase,21747,200,1.27 [1.10-1.46],0.0013661881510636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP3,Stromelysin-1,22610,209,1.33 [1.06-1.68],0.0151545283915165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP7,Matrilysin,22127,199,1.33 [1.02-1.74],0.0332362549294937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MOG,Myelin-oligodendrocyte glycoprotein,22761,210,1.49 [1.04-2.13],0.0283566760990061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MPHOSPH8,M-phase phosphoprotein 8,22162,199,1.17 [1.00-1.38],0.0488214881569876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRC1,Macrophage mannose receptor 1,19664,165,1.75 [1.07-2.86],0.0257738807924921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MSR1,Macrophage scavenger receptor types I and II,22765,209,1.57 [1.20-2.06],0.0009382602713163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MUC13,Mucin-13,22060,200,1.35 [1.07-1.71],0.0112943240087561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MVK,Mevalonate kinase,22144,200,1.22 [1.05-1.41],0.0110066313521664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYBPC1,"Myosin-binding protein C, slow-type",19653,166,1.39 [1.15-1.67],0.0005936654044975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYL3,Myosin light chain 3,19166,163,1.27 [1.04-1.55],0.0200410091784914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYOM2,Myomesin-2,18980,160,1.62 [1.27-2.06],0.0001205614312407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYOM3,Myomesin-3,19241,159,1.22 [1.03-1.43],0.0178841989800269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NBL1,Neuroblastoma suppressor of tumorigenicity 1,22673,210,1.95 [1.27-2.99],0.0021023416612356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCAM2,Neural cell adhesion molecule 2,22610,209,0.60 [0.38-0.96],0.0314069417422183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCS1,Neuronal calcium sensor 1,22761,210,1.53 [1.00-2.33],0.047819691976001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",22080,202,1.18 [1.03-1.34],0.0146020178046683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NECTIN2,Nectin-2,22541,212,1.94 [1.34-2.80],0.0004095812182326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NECTIN4,Nectin-4,22673,210,1.86 [1.36-2.54],0.0001001328474153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEFL,Neurofilament light polypeptide,21992,200,1.51 [1.17-1.94],0.0015626167017145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NELL1,Protein kinase C-binding protein NELL1,22673,210,0.70 [0.53-0.93],0.0128518815570445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFASC,Neurofascin,22801,212,1.70 [1.13-2.55],0.0115490932148204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NGFR,Tumor necrosis factor receptor superfamily member 16,19653,166,1.55 [1.07-2.26],0.0217700392681321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NID2,Nidogen-2,22610,209,1.24 [1.06-1.45],0.0079338640270454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOS1,"Nitric oxide synthase, brain",22060,200,1.62 [1.32-1.98],3.349281658242326e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPDC1,Neural proliferation differentiation and control protein 1,22584,212,1.61 [1.15-2.24],0.005187180611391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NTproBNP,N-terminal prohormone of brain natriuretic peptide,22584,212,1.16 [1.04-1.28],0.0053120570761812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUCB2,Nucleobindin-2,22717,210,1.49 [1.08-2.05],0.0152706861015274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OCLN,Occludin,19611,164,1.53 [1.12-2.09],0.007276978846615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OGN,Mimecan,22610,209,1.54 [1.17-2.02],0.0017938838847841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),P4HB,Protein disulfide-isomerase,22487,209,1.54 [1.13-2.11],0.0066047494401151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAK4,Serine/threonine-protein kinase PAK 4,22060,200,1.24 [1.03-1.50],0.0232855588631857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PALM2,Paralemmin-2,19617,166,1.53 [1.06-2.22],0.0245175029056533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCARE,Photoreceptor cilium actin regulator,19004,158,0.79 [0.62-1.00],0.0494533944548955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDCD1LG2,Programmed cell death 1 ligand 2,22474,209,1.59 [1.11-2.29],0.0125209726043299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDGFC,Platelet-derived growth factor C,22080,202,1.61 [1.10-2.35],0.0140709396687501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDGFRA,Platelet-derived growth factor receptor alpha,22584,212,1.53 [1.01-2.32],0.0430120391606575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",22080,202,1.31 [1.08-1.59],0.0060475533839233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDZD2,PDZ domain-containing protein 2,18980,160,1.28 [1.03-1.60],0.0289212653462063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,19069,160,1.61 [1.21-2.14],0.0012444111133755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGF,Placenta growth factor,22801,212,1.97 [1.31-2.98],0.0011917598169251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,22387,210,1.67 [1.14-2.44],0.0087172099235497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PIGR,Polymeric immunoglobulin receptor,22308,206,1.77 [1.27-2.46],0.0007276387772044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,22610,209,2.03 [1.40-2.96],0.0002055428839541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PILRA,Paired immunoglobulin-like type 2 receptor alpha,22610,209,1.63 [1.22-2.18],0.0011019127638177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PILRB,Paired immunoglobulin-like type 2 receptor beta,22584,212,1.33 [1.07-1.66],0.0117663187358039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLA2G15,Phospholipase A2 group XV,22673,210,1.64 [1.05-2.55],0.0291005891976001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLA2G7,Platelet-activating factor acetylhydrolase,22610,209,0.56 [0.40-0.80],0.0013000317204297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLAUR,Urokinase plasminogen activator surface receptor,22426,205,2.86 [1.90-4.29],4.165512594024813e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLXNB2,Plexin-B2,22750,212,1.73 [1.07-2.80],0.0267008653093305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),POMC,Pro-opiomelanocortin,19166,163,0.75 [0.61-0.94],0.0112766866813509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP3R1,Calcineurin subunit B type 1,22387,210,1.44 [1.07-1.93],0.0157778196502003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",22144,200,1.26 [1.06-1.49],0.0076915155125749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PREB,Prolactin regulatory element-binding protein,22144,200,1.63 [1.16-2.31],0.0052915574363555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKAB1,5'-AMP-activated protein kinase subunit beta-1,22144,200,1.25 [1.01-1.56],0.0424899754298726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRSS8,Prostasin,22492,208,1.63 [1.23-2.17],0.000780879075874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSMG4,Proteasome assembly chaperone 4,19069,160,0.73 [0.55-0.97],0.0309265444268726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTGDS,Prostaglandin-H2 D-isomerase,22429,211,1.75 [1.24-2.47],0.001401219645022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTK7,Inactive tyrosine-protein kinase 7,22060,200,1.42 [1.02-1.97],0.0383644029033433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRN2,Receptor-type tyrosine-protein phosphatase N2,22321,210,1.60 [1.13-2.28],0.0087976542291019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PZP,Pregnancy zone protein,19683,165,0.73 [0.54-0.99],0.0449573840909745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB6B,Ras-related protein Rab-6B,22060,200,1.27 [1.02-1.58],0.0352582643728702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RARRES1,Retinoic acid receptor responder protein 1,22080,202,1.37 [1.04-1.82],0.0275470167318216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RARRES2,Retinoic acid receptor responder protein 2,22735,212,1.28 [1.01-1.63],0.0443207234923729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBFOX3,RNA binding protein fox-1 homolog 3,19611,164,1.58 [1.18-2.10],0.0019765932838604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBP2,Retinol-binding protein 2,22474,209,1.30 [1.12-1.51],0.0006363509100286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBP5,Retinol-binding protein 5,22474,209,1.33 [1.08-1.64],0.0064730896572053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG1A,Lithostathine-1-alpha,22460,209,1.52 [1.24-1.87],4.828451300154898e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG1B,Lithostathine-1-beta,22865,212,1.35 [1.12-1.62],0.0015306806206432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG3A,Regenerating islet-derived protein 3-alpha,22865,212,1.30 [1.09-1.54],0.0033735246383019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG4,Regenerating islet-derived protein 4,22603,205,1.58 [1.27-1.98],4.429833470990467e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RELT,Tumor necrosis factor receptor superfamily member 19L,22610,209,1.83 [1.25-2.67],0.0018245801737009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REN,Renin,22584,212,1.20 [1.05-1.37],0.008123797834504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RICTOR,Rapamycin-insensitive companion of mTOR,19069,160,0.65 [0.43-0.98],0.0417249441728062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASE6,Ribonuclease K6,19520,163,1.47 [1.04-2.08],0.0296779367540018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASET2,Ribonuclease T2,22772,210,1.71 [1.15-2.55],0.0079106370975122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RPS10,40S ribosomal protein S10,18980,160,1.36 [1.01-1.83],0.0406429763818907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RSPO1,R-spondin-1,22387,210,1.43 [1.00-2.02],0.0474647862056986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RSPO3,R-spondin-3,22761,210,1.61 [1.08-2.41],0.0199495160913159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RUVBL1,RuvB-like 1,22080,202,1.13 [1.02-1.26],0.0167891352601572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A14,Protein S100-A14,19611,164,1.31 [1.02-1.68],0.0368992063544064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A16,Protein S100-A16,22026,200,1.21 [1.01-1.46],0.0422493590190533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SATB1,DNA-binding protein SATB1,19611,164,1.80 [1.27-2.54],0.0009207190352308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARA5,Scavenger receptor class A member 5,22765,209,1.60 [1.08-2.38],0.0191852907871197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARB1,Scavenger receptor class B member 1,22060,200,1.26 [1.07-1.49],0.0056739404397177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARB2,Lysosome membrane protein 2,21964,209,1.77 [1.28-2.45],0.000582930357325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARF2,Scavenger receptor class F member 2,22765,209,1.57 [1.04-2.37],0.0309726976444348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCG2,Secretogranin-2,22644,210,1.52 [1.06-2.18],0.0215961845382913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCG3,Secretogranin-3,22603,205,1.77 [1.23-2.54],0.0020262422153177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCGN,Secretagogin,22144,200,1.34 [1.03-1.74],0.0296126031103327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SDC1,Syndecan-1,22584,212,1.40 [1.04-1.88],0.024229386376427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA6,Corticosteroid-binding globulin,19683,165,2.86 [1.15-7.15],0.0242782202412421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA7,Thyroxine-binding globulin,19683,165,0.43 [0.19-0.95],0.0379760882622913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINE2,Glia-derived nexin,19653,166,1.29 [1.03-1.61],0.0262193606264213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPING1,Plasma protease C1 inhibitor,19650,164,2.82 [1.26-6.31],0.0119027200710782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SESTD1,SEC14 domain and spectrin repeat-containing protein 1,22060,200,1.24 [1.04-1.49],0.0186590389229225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SETMAR,Histone-lysine N-methyltransferase SETMAR,22310,209,1.46 [1.00-2.14],0.0493337609087164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,19004,158,1.30 [1.08-1.57],0.0052931069689115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIAE,Sialate O-acetylesterase,22637,209,1.35 [1.04-1.75],0.0243501454722139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC1,Sialoadhesin,22676,208,1.77 [1.34-2.32],4.491100133212176e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC8,Sialic acid-binding Ig-like lectin 8,19166,163,1.58 [1.14-2.19],0.006082214465455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLAMF1,Signaling lymphocytic activation molecule,22144,200,1.31 [1.06-1.62],0.0131689657910647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLAMF6,SLAM family member 6,22080,202,1.57 [1.16-2.12],0.003526737736565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLAMF8,SLAM family member 8,22080,202,1.35 [1.07-1.70],0.0120584289710784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC16A1,Monocarboxylate transporter 1,22060,200,1.24 [1.03-1.49],0.0241961970241715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC27A4,Long-chain fatty acid transport protein 4,22060,200,1.23 [1.05-1.45],0.0126644064463631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC39A14,Zinc transporter ZIP14,22060,200,1.60 [1.21-2.12],0.0008811641533744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SOD2,"Superoxide dismutase [Mn], mitochondrial",22610,209,1.62 [1.22-2.15],0.0008894714400812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SORCS2,VPS10 domain-containing receptor SorCS2,22080,202,1.72 [1.25-2.39],0.0010130545541365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINK1,Serine protease inhibitor Kazal-type 1,22610,209,1.62 [1.26-2.06],0.0001238226415037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINK6,Serine protease inhibitor Kazal-type 6,22761,210,1.29 [1.02-1.63],0.0338617469333462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINT1,Kunitz-type protease inhibitor 1,22543,209,1.70 [1.09-2.67],0.0198468035543132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINT2,Kunitz-type protease inhibitor 2,22676,208,1.65 [1.22-2.24],0.0012760309087952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPON1,Spondin-1,22603,205,1.60 [1.16-2.22],0.0047319033399562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPON2,Spondin-2,22477,211,1.97 [1.41-2.74],6.028621302292978e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPP1,Osteopontin,22837,212,1.39 [1.08-1.80],0.0117987050010748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SRPX,Sushi repeat-containing protein SRPX,19653,166,1.53 [1.01-2.32],0.0448884217464108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",22474,209,1.31 [1.01-1.70],0.0403823977815409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",22865,212,1.49 [1.03-2.15],0.0352711258367414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TDRKH,Tudor and KH domain-containing protein,22060,200,1.18 [1.02-1.36],0.0245236084344512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFF1,Trefoil factor 1,22491,208,1.23 [1.07-1.41],0.0028192191577473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFF2,Trefoil factor 2,22636,206,1.31 [1.07-1.60],0.008539149655906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFF3,Trefoil factor 3,22579,211,1.39 [1.09-1.77],0.0071467399474287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFA,Protransforming growth factor alpha,22522,211,1.40 [1.10-1.79],0.0062694153661139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFBR2,TGF-beta receptor type-2,22673,210,1.56 [1.13-2.15],0.0063008249876124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFBR3,Transforming growth factor beta receptor type 3,22865,212,1.76 [1.20-2.59],0.0041545027468857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THBD,Thrombomodulin,22584,212,1.50 [1.01-2.22],0.045339475704159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THBS2,Thrombospondin-2,22610,209,1.42 [1.06-1.92],0.0201591391628919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THPO,Thrombopoietin,22162,199,1.40 [1.02-1.92],0.0356777610368946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THY1,Thy-1 membrane glycoprotein,22765,209,1.69 [1.13-2.54],0.0104993799997507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMP1,Metalloproteinase inhibitor 1,22368,210,1.96 [1.33-2.88],0.0006046508019984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMP3,Metalloproteinase inhibitor 3,22676,208,1.11 [1.02-1.22],0.0184631263681056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMP4,Metalloproteinase inhibitor 4,22610,209,1.43 [1.09-1.89],0.0112146067091022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMED1,Transmembrane emp24 domain-containing protein 1,19299,165,0.60 [0.43-0.83],0.0018814158134774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMSB10,Thymosin beta-10,22610,209,1.20 [1.02-1.42],0.0290149556299275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,22387,210,1.78 [1.32-2.39],0.0001473393465252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,22387,210,1.30 [1.08-1.56],0.0064588903780953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,22801,212,1.82 [1.38-2.38],1.720329547241292e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,22673,210,1.84 [1.35-2.50],0.000111002980263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,22603,205,1.38 [1.03-1.86],0.0329564817797717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF14,Tumor necrosis factor receptor superfamily member 14,22603,205,2.13 [1.50-3.03],2.827227693947553e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF19,Tumor necrosis factor receptor superfamily member 19,22761,210,1.62 [1.16-2.26],0.0049008770564679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,22610,209,2.24 [1.60-3.15],2.965444590751708e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,22610,209,1.55 [1.25-1.92],5.75199368460612e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF21,Tumor necrosis factor receptor superfamily member 21,22765,209,1.54 [1.01-2.34],0.044748329935119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF4,Tumor necrosis factor receptor superfamily member 4,22768,212,1.42 [1.06-1.90],0.0192389420131645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,22387,210,1.45 [1.21-1.74],6.495547602370509e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF9,Tumor necrosis factor receptor superfamily member 9,22387,210,1.39 [1.09-1.77],0.0079080842793514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF13,Tumor necrosis factor ligand superfamily member 13,22676,208,2.43 [1.58-3.73],5.59963140032946e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPP1,Tripeptidyl-peptidase 1,22413,203,1.33 [1.04-1.70],0.0209924215998883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPSAB1,Tryptase alpha/beta-1,22769,212,1.39 [1.10-1.75],0.0062005771511687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TREM2,Triggering receptor expressed on myeloid cells 2,22569,205,1.43 [1.14-1.79],0.0020500272646306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TREML2,Trem-like transcript 2 protein,22610,209,1.58 [1.14-2.20],0.0062919113404718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSHB,Thyrotropin subunit beta,22584,212,0.83 [0.71-0.96],0.0135628352577968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSPAN8,Tetraspanin-8,19559,166,1.16 [1.01-1.34],0.0384840480145187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXNDC5,Thioredoxin domain-containing protein 5,22765,209,1.21 [1.02-1.45],0.0318635023302407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ULBP2,UL16-binding protein 2,22387,210,1.48 [1.09-1.99],0.0108814527603666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UMOD,Uromodulin,22800,212,0.79 [0.64-0.97],0.0261719568762359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VCAM1,Vascular cell adhesion protein 1,22659,212,1.75 [1.15-2.67],0.0092158414196512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VPS28,Vacuolar protein sorting-associated protein 28 homolog,19299,165,1.25 [1.01-1.54],0.0392709016115821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSIG4,V-set and immunoglobulin domain-containing protein 4,22579,208,2.19 [1.70-2.82],1.335054255838028e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,22545,212,1.22 [1.02-1.47],0.0329730065878008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,22162,199,1.23 [1.03-1.47],0.0248536450255347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VWA1,von Willebrand factor A domain-containing protein 1,22724,210,1.38 [1.03-1.85],0.0301960673688381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VWC2,Brorin,22317,209,1.50 [1.11-2.03],0.0083081946443929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WASF3,Wiskott-Aldrich syndrome protein family member 3,22060,200,1.19 [1.03-1.38],0.0219879397107803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WFDC2,WAP four-disulfide core domain protein 2,21463,201,1.85 [1.44-2.38],1.7175503669055513e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",22310,209,0.71 [0.53-0.95],0.0230366554739316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WNT9A,Protein Wnt-9a,22144,200,1.75 [1.21-2.54],0.0030948466520125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),XG,Glycoprotein Xg,22765,209,1.48 [1.04-2.11],0.0290319364812146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),XRCC4,DNA repair protein XRCC4,22060,200,1.35 [1.01-1.80],0.0436671892729629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YOD1,Ubiquitin thioesterase OTU1,18980,160,0.78 [0.61-1.00],0.049517014857261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZNF75D,Zinc finger protein 75D,19299,165,0.66 [0.50-0.89],0.0056354014643704
